The Philadelphia HIV Resource Finder allows Philadelphians to search for treatment and prevention resources throughout the city.
A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...
Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure ...
Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...
An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, ...
Young girls and boys were urged to seek guidance, ask questions, and use the available health services at Rabie Ridge Clinic ...
LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...
AllAfrica on MSN
Uganda Targets Less Than 10,000 New HIV Infections By 2031
Uganda is intensifying efforts to cut new HIV infections to under 10,000 annually by 2031, officials warned, as experts caution that young people remain the most vulnerable group and could reverse ...
Maine taxpayers could be responsible for even more funding if the federal government cuts support for Title X and MaineCare.
INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results